Navigation Links
Dozens More H5N1 Bird Flu Cases in Germany

German authorities on Thursday reported 38 new cases of the feared H5N1 strain of bird flu which can kill huamns in the country's east .

The regional authorities in Sangerhausen in the state of Saxony-Anhalt said 38 dead birds found on the shores of an artificial lake near the town of Kelbra had all tested positive.

Saxony-Anhalt is the fourth of Germany's 16 states to report cases of H5N1 bird flu since late last month, when it struck down six wild birds in the southern city of Nuremberg in Bavaria.

On Tuesday, a bird found on the other side of the lake at Kelbra in the state of Thueringen was confirmed to have had H5N1 bird flu.

Cases have also been reported near Leipzig in the neighbouring eastern state of Saxony, bordering the Czech Republic which is battling a more severe outbreak of the H5N1 avian flu.

Germany's Friedrich Loeffler Institute, the national veterinary laboratory, has suggested the disease could have jumped the border from the Czech side where it has infected turkey and chicken farms.

In Germany, the new outbreak has been restricted to swans, geese and other wild birds and has not affected poultry farms.

Germany battled a widespread bird flu epidemic in 2006. It broke out on the Baltic Sea island of Ruegen and spread to six states, including Bavaria.

The disease spread to mammals, infecting three cats and a stone marten, but did not affect humans.


'"/>




Page: 1

Related medicine news :

1. Dozens of Panamanians Gravely Ill from Toxic Substance from China
2. China reports declining number of SARS Cases
3. Dengue in Delhi – 26 Cases reported and 3 dea
4. Dengue Epidemic in West Bengal: Over 1000 New Cases and 15 dead
5. HIV Cases Steadily Increasing In China With The Toll Over 1.26 Lakh
6. Plump Infants Getting Obese Later In Life In More Cases
7. Only 30 Polio Cases Reported In India
8. Human Bird Flu Cases Total 130: WHO
9. Three More Bird Flu Cases Reported By China
10. AIDS Cases On The Rise In West Bengal
11. WBSACS Says Number Of AIDS Cases On The Rise
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Dozens More Bird Flu Cases Germany

(Date:7/25/2008)... New program delivers immediate co...[24-hour telephone access to language interpreters...g multilingual solutions. , ...LLE® http://www.lle-inc.com/index.html [(Lan...ider of interpretation, translation, and language ...
(Date:7/25/2008)... The Drug Information Association ...ill host the Critical Path Initiative (CPI) on the...16; Bethesda, MD) and the Critical Path Transporte... Horsham, PA (PRWEB) July 25...mation Association (DIA)] and the Food and Drug Ad...
(Date:7/24/2008)...TON-SALEM, N.C. Researchers at Wake Forest Unive...-standing clinical belief that the hepatitis C vir...restore itself after HIV patients are treated with..., Hepatitis C (HCV) infection is more serious in...e, according to the Centers for Disease Control. I...
(Date:7/24/2008)...UTH, Minn., July 24 /PRNewswire-FirstCall/ -- ev3 ... to report its 2008 second quarter and,year-to-dat...second quarter,and year-to-date financial results ...ding hours., The company will host a conference c...m. Eastern Time) on Tuesday, July 29, 2008. ev3,ma...
Breaking Medicine News(10 mins):Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Researchers disprove long-standing belief about HIV treatment 2Health News:Researchers disprove long-standing belief about HIV treatment 3Health News:ev3 Inc. Announces Revised Date for 2008 Second Quarter Financial Results and Conference Call 2
...ors of All India Institute of Medical Sciences (AI...ll //in Lok Sabha on Thursday intensified with fiv...ike - Dr Anil Sharma, spokesman of the AIIMS Resid...the doctors would continue attending duty and serv...
...Ease Dietary Supplement, a product containing the ...ndent on it when used just for few months. // Est...which should be consumed only under a practitioner...r of side effects like loss of memory, confusion, ...
... wish-list of many scientists and sufferers the wo...–child of an //Australian scientist, whose perseve...th of cancer cells, seems to have paid off. Prof...king on his ‘baby’ for the past 20 years, may just...
...mptoms of high fever and bodyache has killed 12 ch...g to official sources, 12 children died in two or ...strict due to the disease commonly referred as 'kh...a dozen children were suffering from the same dise...
Other Medicine News:
(Date:7/24/2008)... Ortho-McNeil Neurologics, a,division of Ortho-McN...,that the U.S. Food and Drug Administration (FDA) ...topiramate), based on studies submitted in,respons...he use of TOPAMAX,in pediatric patients aged 1 to ...on to granting pediatric exclusivity, the FDA is c...
(Date:7/24/2008)...cology Patient Accrual, DENVER, July 24 /PRNewswi...anization (RMO), has contracted with five leading ...ite management services for their,clinical trials ...The new,trials include the following disease indic...tic Breast Cancer, Metastatic Sarcoma, Chronic Mye...
(Date:7/23/2008)... print edition of Clinical Ch.../- A Roche Diagnostics-sponsored,pilo...e natriuretic peptide,(NT-proBNP) confirms the pot...in predicting the risk of cardiovascular adverse e...al anti-inflammatory drugs of,the COX inhibitor cl...
(Date:7/23/2008)...Code BioPharmaceutics, Inc.,an emerging biopharma...,results demonstrating the utility of their lead d...chronic blood disorder paroxysmal nocturnal,hemogl...nted at the XXII,International Complement Workshop...only treatment currently available for PNH patient...
Breaking Medicine Technology:FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Glowing films developed by UC San Diego chemists reveal traces of explosives 3416 1Glowing films developed by UC San Diego chemists reveal traces of explosives 3416 2Origin of cells for connective tissues of skull and face challenged 3415 1Origin of cells for connective tissues of skull and face challenged 3415 2Origin of cells for connective tissues of skull and face challenged 3415 3Journal of Ultrasound In Medicine features bioeffects consensus report 20179 1Graduates Forced to Join Millions of Uninsured Americans 20174 1Graduates Forced to Join Millions of Uninsured Americans 20174 2Graduates Forced to Join Millions of Uninsured Americans 20174 3
...007 - Gilead,Sciences, Inc. (Nasdaq:GILD) today an... evaluating the company,s once-daily,anti-HIV drug...r,DF) 300 mg as a potential treatment for chronic ... efficacy endpoint. The study shows,that Viread is...l,drug Hepsera(R) (adefovir dipivoxil) among patie...
...-FirstCall/ --,NeurogesX, Inc. announced today the...se 3 trial in postherpetic neuralgia (PHN).,Misha-... University,of Wisconsin in Madison and lead acade...present the results of the study in a,June 8 poste...Neuropathic Pain in Berlin, Germany. Dr. Backonja,...
Other Medicine Technology:Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 2Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 3Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 4Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 5Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 6Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 7NeurogesX Announces Presentation of Positive Phase 3 Clinical Data,at the Second International Congress on Neuropathic Pain Meeting,(NeuPSIG) 2NeurogesX Announces Presentation of Positive Phase 3 Clinical Data,at the Second International Congress on Neuropathic Pain Meeting,(NeuPSIG) 3NeurogesX Announces Presentation of Positive Phase 3 Clinical Data,at the Second International Congress on Neuropathic Pain Meeting,(NeuPSIG) 4
...eeds I-125 are brachytherapy sources which are imp...mors, especially in the prostate. The seeds remain...ic effect, i.e. after radioactive decay is complet...ey are supplied in a sterile form. Isoseeds I-125 ...
...mirrors for complete anterior chamber angle viewin...or easy handling and stability. Choice large or sm...llows static or dynamic gonioscopy without methylc... coating protects mirrors and is compatible with m...
Three mirrors of 64, 67 and 73 and a small diameter contact surface for use without methylcellulose. The fundus can be viewed through the central axis of the lens. Multi-layer polymer coating protect
West lacrimal cannula blunt tip with side port.
Medicine Products: